Revolution Medicines Inc (RVMD : NASDAQ)
Common Stock
$199.86
USD
+9.12 (4.78%)
Last updated: 2026-09-24
Follow RVMD
RVMD
Revolution Medicines Inc
WealthAwesomePerformance
1 Day
+4.78%
1 Week
+1.48%
1 Month
-5.45%
YTD
+26.68%
Key Statistics
Market Cap
$42.84B
52W High
$224.31
52W Low
$44.05
P/E Ratio
-
50 Day MA
$199.82
200 Day MA
$142.15
Beta
1.41
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/24/2026 | $190.15 | $201.28 | $189.84 | $199.86 | $199.86 | 4,066,872 |
| 9/23/2026 | $193.30 | $196.71 | $189.05 | $190.74 | $190.74 | 2,124,868 |
| 9/22/2026 | $191.56 | $195.28 | $191.22 | $192.86 | $192.86 | 1,828,565 |
| 9/21/2026 | $192.60 | $194.93 | $190.57 | $192.76 | $192.76 | 1,888,247 |
| 9/18/2026 | $197.00 | $197.10 | $188.18 | $190.95 | $190.95 | 5,938,100 |
| 9/17/2026 | $198.53 | $202.02 | $194.80 | $196.94 | $196.94 | 1,810,661 |
| 9/16/2026 | $204.84 | $205.15 | $193.58 | $195.92 | $195.92 | 3,036,953 |
| 9/15/2026 | $206.98 | $207.00 | $200.24 | $204.86 | $204.86 | 1,268,500 |
| 9/14/2026 | $203.50 | $206.55 | $200.17 | $205.11 | $205.11 | 1,273,600 |
| 9/11/2026 | $204.98 | $206.36 | $197.81 | $203.77 | $203.77 | 1,378,500 |
Analyst Price Targets
Based on 12 analysts covering RVMD · as of Sep 25, 2026
Wall Street analysts forecast RVMD stock price to rise 27.0% over the next 12 months.
Consensus
Strong Buy4.67 / 5.00
Avg. Target
US$253.92
+27.0% Upside
Previously US$253.30 on Sep 23, 2026
Current Price
US$199.86
Last close
Analyst Breakdown (12 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on RVMD's historical volatility
30-Day Vol
35.2%
Annualized
90-Day Vol
38.1%
Annualized
Trend (90d)
+27.3%
Annualized drift
90d Mean
US$220.33
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$206.46 | US$182.87 – US$233.10 |
| 60 trading days | US$213.29 | US$179.65 – US$253.21 |
| 90 trading days | US$220.33 | US$178.57 – US$271.87 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Revolution Medicines Inc
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Financials
- Revenue (TTM)
- $742,000
- EBITDA
- $-1.62B
- Profit Margin
- 0.00%
- ROE (TTM)
- -79.09%
- EPS (Diluted)
- -9.30
- Book Value
- 12.16
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About RVMD.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| RPGL | Republic Power Group Limited Class A Ordinary Shares | $14.69 | +1363.23% |
| KITT | Nauticus Robotics Inc. | $2.93 | +459.21% |
| ZWZZT | NASDAQ TEST STOCK | $24.50 | +144.51% |
| SRZN | Surrozen Inc | $33.68 | +108.42% |
| GLND | Greenland Energy Company Common Stock | $5.35 | +83.85% |
| PMAX | Powell Max Limited Class A Ordinary Shares | $1.65 | +80.62% |
| STAK | STAK Inc. Ordinary Shares | $1.44 | +53.19% |
| PFSA | Profusa, Inc. Common Stock | $3.03 | +47.80% |
RVMD.US news timeline
1 article covering RVMD.US, most recent first
Latest